PEOPLE - Biometric Research Institute (US) makes two new appointments:
This article was originally published in Clinica
Biometric Research Institute (US) has made two new appointments. Dr Robert Davis is vice-president of project operations division. He was formerly with Pharmaco LSR (US). Dr Charles Finn is named executive director of regulatory affairs division. Prior to joining BRI he was director of regulatory and government affairs at Genetics Institute (US).
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.